NeurologyLive® Friday 5 — February 16, 2024

Welcome to NeurologyLive^®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive^®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: Epilepsy Awareness and First Aid for Seizures in 2024: Claude Steriade, MD, CM

The epileptologist at NYU Langone Health and associate professor of neurology at NYU Grossman School of Medicine talked about the ongoing need to improve public awareness and education on seizure first aid. [WATCH TIME: 3 minutes]

2: Advancements and Challenges in Genetic Treatments for Neuromuscular Diseases: John W. Day, MD, PhD

Ahead of the 2024 MDA Conference, the medical advisor and care center director at Muscular Dystrophy Association talked about the track sessions he will be cochairing at the meeting. [WATCH TIME: 5 minutes]

3: A Medical Preview of 2024 for Multiple Sclerosis and Related Disorders: Jiwon Oh, MD, PhD

The staff neurologist and medical director of the Barlo Multiple Sclerosis Program at St Michaels Hospital shared thoughts on the promising advancements in the multiple sclerosis field for 2024. [WATCH TIME: 5 minutes]

4: NeuroVoices: Stephan A. Mayer, MD, FCCM, FNCS, on the Urgent Need to Improve Intracerebral Hemorrhage Care

In this week's NeuroVoices Q&A, the director of neurocritical care and emergency neurology services at Westchester Medical Center Health System discussed the call for a paradigm shift in stroke care with a focus on intracerebral hemorrhage.

5: Monitoring Patients After a Change in Treatment Regimen

In a new episode of the "CMSC Consensus Panel Guidance on the Use of Serum Neurofilament Light Chain in the Management of Multiple Sclerosis" video series, Mark Freedman, MD, MSc, Tanuja Chitnis, MD, and Ahmed Obeidat, MD, PhD, review conditions under which they would assess treatment success for patients who have changed therapies.